Parabilis director reports 105,414 IPO-convertible shares
Parabilis Medicines, Inc. director Alexis Borisy filed an initial ownership report showing a direct holding of Series F Preferred Stock.
Rhea-AI Filing Summary
Parabilis Medicines, Inc. director Alexis Borisy filed an initial ownership report showing a direct holding of Series F Preferred Stock. Each share of this preferred stock is convertible into Common Stock on a 1 to 0.6498 basis at the holder’s option and has no expiration date. The filing notes that this preferred stock will automatically convert into 105,414 shares of Common Stock immediately prior to the closing of the company’s initial public offering and without any payment of additional consideration. The filing does not report any new purchase or sale, only the existing position.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Borisy Alexis
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Series F Preferred Stock | -- | -- | -- |
Holdings After Transaction:
Series F Preferred Stock — 105,414 contracts (Direct)
Footnotes (1)
- F1. Each share of Series F Preferred Stock (the "Preferred Stock") is convertible into Common Stock on a 1 to 0.6498 basis at any time at the option of the holder, and will automatically convert into the number of shares shown in Column 3 immediately prior to the closing of the Issuer's initial public offering (the "IPO") and without payment of consideration. The Preferred Stock has no expiration date.
Key Figures
Underlying common shares: 105,414 shares
Conversion ratio: 1 to 0.6498
Exercise price: $0.0000 per share
3 metrics
Underlying common shares
105,414 shares
Shares of Common Stock underlying Series F Preferred Stock
Conversion ratio
1 to 0.6498
Series F Preferred Stock to Common Stock conversion basis
Exercise price
$0.0000 per share
Conversion/exercise price for Series F Preferred Stock
Key Terms
Series F Preferred Stock, convertible into Common Stock, initial public offering, underlying security
4 terms
Series F Preferred Stock financial
"Each share of Series F Preferred Stock (the "Preferred Stock") is convertible"
Series F preferred stock is a class of company shares that gives holders priority over common shareholders for dividend payments and for getting money back if the company is sold or liquidated, much like a ticket that moves you to the front of the line. These shares often carry a fixed dividend and special rights—sometimes including conversion into common stock—so investors consider them when weighing income, downside protection and potential ownership dilution.
convertible into Common Stock financial
"is convertible into Common Stock on a 1 to 0.6498 basis at any time"
initial public offering financial
"immediately prior to the closing of the Issuer's initial public offering (the "IPO")"
An initial public offering (IPO) is when a private company first sells its shares to the public and becomes a stock-listed company. It matters because it allows the company to raise money from a wide range of investors, helping it grow, while giving early shareholders a way to sell some of their ownership.
underlying security financial
"underlying_security_title": "Common Stock","underlying_security_shares": "105414.0000""
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Alexis Borisy report in the Parabilis (PBLS) Form 3 filing?
Alexis Borisy reported a direct holding of Series F Preferred Stock in Parabilis Medicines. This preferred stock is convertible into Common Stock and will automatically convert into 105,414 shares immediately before the company’s initial public offering, reflecting his pre-IPO equity position.
What is the conversion ratio for Parabilis (PBLS) Series F Preferred Stock?
Each share of Parabilis Series F Preferred Stock is convertible into Common Stock on a 1 to 0.6498 basis. This means every preferred share turns into 0.6498 of a Common Share, and the preferred stock will convert automatically into the disclosed 105,414 common shares before the IPO.
Does the Parabilis (PBLS) Series F Preferred Stock reported in the Form 3 have an expiration date?
The Series F Preferred Stock reported in the Form 3 has no expiration date. It can be converted into Common Stock at any time at the holder’s option and will also automatically convert into 105,414 common shares immediately prior to the closing of the company’s initial public offering.
Does the Parabilis (PBLS) Form 3 show any insider buying or selling activity?
The Form 3 does not show any new insider buying or selling activity. It is an initial ownership report that lists Alexis Borisy’s existing holdings of Series F Preferred Stock and the 105,414 underlying common shares that will result from its automatic conversion before the IPO.
AI-generated analysis. How Rhea-AI works. Not financial advice.
